Singapore Institute of Advanced Medicine Holdings 9G2.SI · SGD

N/A · SGX · 🇸🇬 Singapore

Compare

0.02

+9.52%

Close of 6 Nov 2026, in SGD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SGD, from our data supplier.

FY2026

Revenue

SGD 15.7m

FY2022FY2026

Net income

−SGD 23.9m

FY2022FY2026

Free cash flow

−SGD 4.1m

FY2022FY2026

Shareholders' equity

SGD 52.9m

FY2022FY2026

Income statement

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022
Revenue	SGD 15.7m	SGD 15.7m	SGD 16.6m	SGD 16.2m	SGD 13.8m
Gross profit	SGD 14.5m	SGD 14.4m	SGD 15.4m	SGD 15.0m	SGD 12.6m
Net income	−SGD 23.9m	−SGD 26.2m	−SGD 37.4m	−SGD 18.1m	−SGD 12.4m
Diluted earnings per share	-0.01	-0.02	-0.02	-0.01	-0.01

Balance sheet

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022
Total assets	SGD 132.1m	SGD 124.7m	SGD 138.8m	SGD 159.5m	SGD 174.4m
Total liabilities	SGD 79.2m	SGD 69.1m	SGD 57.0m	SGD 114.6m	SGD 120.3m
Debt	SGD 10.9m	SGD 18.8m	SGD 9.7m	SGD 21.1m	SGD 29.9m
Shareholders' equity	SGD 52.9m	SGD 55.6m	SGD 81.7m	SGD 44.9m	SGD 54.1m
Shares outstanding	1,724m	1,724m	1,724m	1,724m	1,724m

Cash flow

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022
Cash from operations	−SGD 3.6m	−SGD 10.6m	−SGD 12.9m	−SGD 3.2m	−SGD 5.8m
Capital spending	−SGD 488,798	−SGD 147,785	−SGD 534,260	−SGD 14.4m	−SGD 4.1m
Free cash flow	−SGD 4.1m	−SGD 10.8m	−SGD 13.5m	−SGD 17.7m	−SGD 9.9m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Jun 2025	Mar 2025	Dec 2024	Jun 2024	Dec 2023
Revenue	SGD 3.7m	SGD 3.8m	SGD 3.7m	SGD 3.9m	SGD 8.0m	SGD 8.1m	SGD 8.5m
Gross profit	SGD 3.3m	SGD 3.5m	SGD 3.4m	SGD 3.6m	SGD 7.4m	SGD 7.5m	SGD 7.9m
Operating income	—	—	—	—	−SGD 11.8m	−SGD 9.7m	−SGD 11.6m
Net income	−SGD 6.6m	−SGD 5.7m	−SGD 8.2m	−SGD 6.2m	−SGD 12.6m	−SGD 16.2m	−SGD 21.2m
Diluted earnings per share	-0.00	-0.00	-0.00	-0.00	-0.01	-0.03	-0.02
Cash from operations	−SGD 4.0m	—	−SGD 2.0m	−SGD 2.0m	—	—	—
Total assets	SGD 132.1m	SGD 122.3m	SGD 124.7m	—	SGD 135.6m	SGD 138.8m	—
Debt	SGD 10.9m	SGD 10.8m	SGD 18.8m	—	SGD 16.0m	SGD 9.7m	—
Shareholders' equity	SGD 52.9m	SGD 44.3m	SGD 55.6m	—	SGD 69.1m	SGD 81.7m	—

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	-5.7%	—	—
Net income	9.8%	—	—

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	92.0%	92.1%	—	—

Valuation history

At each fiscal year end

	FY2026	FY2025	FY2024
Price to earnings	-1.5	-4.5	-1.4
Price to sales	3.1	9.5	10.6

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Singapore Institute of Advanced Medicine Holdings 9G2.SI · SGD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Growth per year

Average margins

Valuation history

Sources and methodology